Integrated bioinformatics analysis shows integrin alpha 3 is a prognostic biomarker for pancreatic cancer

Integrin subunit alpha 3 (ITGA3) expression correlates with the development and prognosis of human cancers. This study aimed to investigate the association of ITGA3 expression with pancreatic cancer (PCa) prognosis. The ITGA3 gene expression data were extracted from The Cancer Genome Atlas (TCGA) pa...

Full description

Bibliographic Details
Main Authors: Hu Fangfang, Zhao Liangtao, Wang Yang, Ye Hao, Tang Haodong, Zhou Jiahua
Format: Article
Language:English
Published: De Gruyter 2022-12-01
Series:Open Medicine
Subjects:
Online Access:https://doi.org/10.1515/med-2022-0606
_version_ 1797947733858844672
author Hu Fangfang
Zhao Liangtao
Wang Yang
Ye Hao
Tang Haodong
Zhou Jiahua
author_facet Hu Fangfang
Zhao Liangtao
Wang Yang
Ye Hao
Tang Haodong
Zhou Jiahua
author_sort Hu Fangfang
collection DOAJ
description Integrin subunit alpha 3 (ITGA3) expression correlates with the development and prognosis of human cancers. This study aimed to investigate the association of ITGA3 expression with pancreatic cancer (PCa) prognosis. The ITGA3 gene expression data were extracted from The Cancer Genome Atlas (TCGA) pancreatic adenocarcinoma (PAAD) cohort and 14 Gene Expression Omnibus microarray datasets. The differences in ITGA3 expression levels between tumor and non-tumor tissues were compared using the Mann–Whitney U test. Cox regression analysis and meta-analysis were performed to detect the association of ITGA3 expression with PCa prognosis. ITGA3 expression was higher in tumors than in controls. Tumors with advanced grades (3/4) had higher ITGA3 levels compared with early-grade tumors (1/2). The meta-analysis of the TCGA PAAD cohort and seven microarray datasets (GSE28735, GSE62452, GSE79668, GSE71729, GSE57495, GSE78229, and GSE21501) showed that ITGA3 was a prognostic biomarker in PCa (hazard ratio (HR) = 1.38, 95% confidence interval (CI) 1.26–1.51, p < 0.00001). Five ITGA3-related genes, including ITGB1 (HR = 1.6), ITGB5 (HR = 1.6), ITGB6 (HR = 1.6), LAMA3 (HR = 2.1), and CD9 (HR = 2.3), correlated with PCa prognosis significantly (p < 0.05). Functional enrichment analysis showed that ITGA3 was related to “hsa04151: PI3K-Akt signaling pathway” and “hsa04510: Focal adhesion.” We concluded that high ITGA3 expression was a potential prognostic biomarker in PCa.
first_indexed 2024-04-10T21:32:25Z
format Article
id doaj.art-2c80818f29d647aaac21e62a53de6210
institution Directory Open Access Journal
issn 2391-5463
language English
last_indexed 2024-04-10T21:32:25Z
publishDate 2022-12-01
publisher De Gruyter
record_format Article
series Open Medicine
spelling doaj.art-2c80818f29d647aaac21e62a53de62102023-01-19T13:04:57ZengDe GruyterOpen Medicine2391-54632022-12-011711935194310.1515/med-2022-0606Integrated bioinformatics analysis shows integrin alpha 3 is a prognostic biomarker for pancreatic cancerHu Fangfang0Zhao Liangtao1Wang Yang2Ye Hao3Tang Haodong4Zhou Jiahua5Department of Hepatobiliary and Pancreatic Surgery, Zhongda Hospital Affiliated to Southeast University, Nanjing, 210009, ChinaDepartment of Hepatobiliary and Pancreatic Surgery, Zhongda Hospital Affiliated to Southeast University, Nanjing, 210009, ChinaDepartment of Hepatobiliary and Pancreatic Surgery, Zhongda Hospital Affiliated to Southeast University, Nanjing, 210009, ChinaSchool of Medicine, Southeast University, Nanjing, 210009, ChinaSchool of Medicine, Southeast University, Nanjing, 210009, ChinaDepartment of Hepatobiliary and Pancreatic Surgery, Zhongda Hospital Affiliated to Southeast University, No. 87 Dingjiaqiao, Gulou District, Nanjing, 210009, ChinaIntegrin subunit alpha 3 (ITGA3) expression correlates with the development and prognosis of human cancers. This study aimed to investigate the association of ITGA3 expression with pancreatic cancer (PCa) prognosis. The ITGA3 gene expression data were extracted from The Cancer Genome Atlas (TCGA) pancreatic adenocarcinoma (PAAD) cohort and 14 Gene Expression Omnibus microarray datasets. The differences in ITGA3 expression levels between tumor and non-tumor tissues were compared using the Mann–Whitney U test. Cox regression analysis and meta-analysis were performed to detect the association of ITGA3 expression with PCa prognosis. ITGA3 expression was higher in tumors than in controls. Tumors with advanced grades (3/4) had higher ITGA3 levels compared with early-grade tumors (1/2). The meta-analysis of the TCGA PAAD cohort and seven microarray datasets (GSE28735, GSE62452, GSE79668, GSE71729, GSE57495, GSE78229, and GSE21501) showed that ITGA3 was a prognostic biomarker in PCa (hazard ratio (HR) = 1.38, 95% confidence interval (CI) 1.26–1.51, p < 0.00001). Five ITGA3-related genes, including ITGB1 (HR = 1.6), ITGB5 (HR = 1.6), ITGB6 (HR = 1.6), LAMA3 (HR = 2.1), and CD9 (HR = 2.3), correlated with PCa prognosis significantly (p < 0.05). Functional enrichment analysis showed that ITGA3 was related to “hsa04151: PI3K-Akt signaling pathway” and “hsa04510: Focal adhesion.” We concluded that high ITGA3 expression was a potential prognostic biomarker in PCa.https://doi.org/10.1515/med-2022-0606pancreatic cancerintegrin alpha 3meta-analysispi3k-akt signaling pathwayextracellular matrix
spellingShingle Hu Fangfang
Zhao Liangtao
Wang Yang
Ye Hao
Tang Haodong
Zhou Jiahua
Integrated bioinformatics analysis shows integrin alpha 3 is a prognostic biomarker for pancreatic cancer
Open Medicine
pancreatic cancer
integrin alpha 3
meta-analysis
pi3k-akt signaling pathway
extracellular matrix
title Integrated bioinformatics analysis shows integrin alpha 3 is a prognostic biomarker for pancreatic cancer
title_full Integrated bioinformatics analysis shows integrin alpha 3 is a prognostic biomarker for pancreatic cancer
title_fullStr Integrated bioinformatics analysis shows integrin alpha 3 is a prognostic biomarker for pancreatic cancer
title_full_unstemmed Integrated bioinformatics analysis shows integrin alpha 3 is a prognostic biomarker for pancreatic cancer
title_short Integrated bioinformatics analysis shows integrin alpha 3 is a prognostic biomarker for pancreatic cancer
title_sort integrated bioinformatics analysis shows integrin alpha 3 is a prognostic biomarker for pancreatic cancer
topic pancreatic cancer
integrin alpha 3
meta-analysis
pi3k-akt signaling pathway
extracellular matrix
url https://doi.org/10.1515/med-2022-0606
work_keys_str_mv AT hufangfang integratedbioinformaticsanalysisshowsintegrinalpha3isaprognosticbiomarkerforpancreaticcancer
AT zhaoliangtao integratedbioinformaticsanalysisshowsintegrinalpha3isaprognosticbiomarkerforpancreaticcancer
AT wangyang integratedbioinformaticsanalysisshowsintegrinalpha3isaprognosticbiomarkerforpancreaticcancer
AT yehao integratedbioinformaticsanalysisshowsintegrinalpha3isaprognosticbiomarkerforpancreaticcancer
AT tanghaodong integratedbioinformaticsanalysisshowsintegrinalpha3isaprognosticbiomarkerforpancreaticcancer
AT zhoujiahua integratedbioinformaticsanalysisshowsintegrinalpha3isaprognosticbiomarkerforpancreaticcancer